title: Partial splenic embolization for hypersplenism before and after liver transplantation.
abstract: Partial splenic embolization (PSE) has been demonstrated to be an effective alternative to splenectomy for patients with hypersplenism. Splenectomy in these patients can be associated with an increased risk of perioperative complications, overwhelming post-splenectomy sepsis (OPSS) and mortality. Partial splenic embolization has the advantages of non- operative intervention and resolution of the complications of hypersplenism. We report the use of this technique in patients with portal hypertension and hypersplenism awaiting liver transplant and patients that have undergone othotopic liver transplantation (OLTx) with persistent hypersplenism post-transplant. Six patients--three awaiting liver transplantation and three patients with persistent hypersplenism status post-OLTx--were treated during the period of 1993-99 at the LSUHSC/Willis Knighton Regional Transplant Center in Shreveport, Louisiana. Three patients were male and three female. All six patients had concomitant thrombocytopenia and neutropenia with platelet counts below 50,000. Patients underwent selective arterial catheterization and embolization via a percutaneous approach with Cook microcoils or PVA particles. The lower pole of the spleen was selectively embolized in all patients to achieve a 30-50% reduction in flow as determined by angiography. Patients were followed with routine computed tomography (CT) scans, platelet and WBC counts for a mean of 26 months in the pre-transplant and 37 months in the post-transplant group. In both groups, all patients had persistent resolution of thrombocytopenia and neutropenia after embolization. In the post-transplant group, one patient had persistent splenomegaly and required splenectomy for pain control. No procedure-related complications occurred in any patient. In this limited review, PSE appears to be a safe and effective treatment of persistent hypersplenism in patients with portal hypertension and those who have undergone OLTx.
authors.affiliation: Department of Surgery, LSU Health Sciences Center, Shreveport, LA 71105, USA.
authors.forename: Christopher S
authors.initials: CS
authors.lastname: Sockrider
authors.forename: Kevin N
authors.initials: KN
authors.lastname: Boykin
authors.forename: John
authors.initials: J
authors.lastname: Green
authors.forename: Andrew
authors.initials: A
authors.lastname: Marsala
authors.forename: Mary
authors.initials: M
authors.lastname: Mladenka
authors.forename: Robert
authors.initials: R
authors.lastname: McMillan
authors.forename: Gazi B
authors.initials: GB
authors.lastname: Zibari
mesh_terms: D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D006971:Hypersplenism / Q000628:therapy*; D006975:Hypertension, Portal / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications / Q000628:therapy*